Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Feb;38(2):319–325. doi: 10.1128/aac.38.2.319

In vitro analysis of the interaction between sucralfate and ketoconazole.

J D Hoeschele 1, A K Roy 1, V L Pecoraro 1, P L Carver 1
PMCID: PMC284447  PMID: 7910723

Abstract

In healthy volunteers, the bioavailability of ketoconazole is significantly decreased during simultaneous administration with sucralfate. In an effort to address this problem, we examined the interaction between sucralfate and ketoconazole in aqueous solutions and in simulated gastric fluid (SGF) at various initial pHs (1, 2, 3, and 6) in the presence or absence of glutamic acid hydrochloride (GA). Samples from each solution were taken 30 min and 2 h after the addition of ketoconazole to evaluate the solubility of ketoconazole over the usual time period of maximal absorption of ketoconazole in humans. The addition of GA to SGF leads to an increase in solution acidity, while the pHs of SGF at a pH of 1, 2, or 3 are markedly increased by the addition of sucralfate. There is a net decrease in acidity from initial pHs for the pH 1, 2, and 3 solutions when GA and sucralfate are combined. The concentration of ketoconazole in SGF at pHs of 1, 2, 3, 4, and 6 was evaluated in order to assess the pH-dependent solubility properties of the drug in the absence of other interacting species. Regardless of the initial pH, combinations of GA plus ketoconazole showed high concentrations of ketoconazole (approximately 100%) in solution. In contrast, significant decreases in the concentration of soluble ketoconazole were observed when sucralfate was mixed with ketoconazole, and, in some cases, soluble ketoconazole was not detectable. The addition of GA to a mixture of sucralfate and ketoconazole leads to a significant increase in the concentration of solubilized ketoconazole. Nonetheless, important sucralfate-ketoconazole interactions are still observed. After 2 h, approximately 35% of the maximal ketoconazole concentration remained in solution. Comparison of the ketoconazole concentrations at different pHs with the predicted concentrations of the three protonation species of ketoconazole [H2(ketoconazole)(2+), H(ketoconazole)(+), or ketoconazole] showed no correlation. Therefore, the decrease in ketoconazole solubility is not simply a reflection of pH perturbation associated with the dissolution of sucralfate. The observed data are most consistent with a model that has H2(ketoconazole)(2+) or H(ketoconazole)(+) forming an electrostatic interaction with the sucralfate polyanion. The findings of this study suggest that the coadministration of sucralfate with other azole antifungal agents should be investigated.

Full text

PDF
319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews F. A., Peterson L. R., Beggs W. H., Crankshaw D., Sarosi G. A. Liquid chromatographic assay of ketoconazole. Antimicrob Agents Chemother. 1981 Jan;19(1):110–113. doi: 10.1128/aac.19.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blum R. A., D'Andrea D. T., Florentino B. M., Wilton J. H., Hilligoss D. M., Gardner M. J., Henry E. B., Goldstein H., Schentag J. J. Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann Intern Med. 1991 May 1;114(9):755–757. doi: 10.7326/0003-4819-114-9-755. [DOI] [PubMed] [Google Scholar]
  3. Carlson J. A., Mann H. J., Canafax D. M. Effect of pH on disintegration and dissolution of ketoconazole tablets. Am J Hosp Pharm. 1983 Aug;40(8):1334–1336. [PubMed] [Google Scholar]
  4. Carver P. L., Berardi R. R., Knapp M. J., Rider J. M., Kauffman C. A., Bradley S. F., Atassi M. In vivo interaction of ketoconazole and sucralfate in healthy volunteers. Antimicrob Agents Chemother. 1994 Feb;38(2):326–329. doi: 10.1128/aac.38.2.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hikal A. H., Walker L. A., Ramachandran T. In vitro and in vivo interactions of furosemide and sucralfate. Pharm Res. 1987 Apr;4(2):171–172. doi: 10.1023/a:1016487507420. [DOI] [PubMed] [Google Scholar]
  6. Knapp M. J., Berardi R. R., Dressman J. B., Rider J. M., Carver P. L. Modification of gastric pH with oral glutamic acid hydrochloride. Clin Pharm. 1991 Nov;10(11):866–869. [PubMed] [Google Scholar]
  7. Lelawongs P., Barone J. A., Colaizzi J. L., Hsuan A. T., Mechlinski W., Legendre R., Guarnieri J. Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin Pharm. 1988 Mar;7(3):228–235. [PubMed] [Google Scholar]
  8. Nagashima R. Development and characteristics of sucralfate. J Clin Gastroenterol. 1981;3(Suppl 2):103–110. [PubMed] [Google Scholar]
  9. Nagashima R., Yoshida N. Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH. Arzneimittelforschung. 1979;29(11):1668–1676. [PubMed] [Google Scholar]
  10. Piscitelli S. C., Goss T. F., Wilton J. H., D'Andrea D. T., Goldstein H., Schentag J. J. Effects of ranitidine and sucralfate on ketoconazole bioavailability. Antimicrob Agents Chemother. 1991 Sep;35(9):1765–1771. doi: 10.1128/aac.35.9.1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Van Tyle J. H. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy. 1984 Nov-Dec;4(6):343–373. doi: 10.1002/j.1875-9114.1984.tb03398.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES